Pacira | PCRX - Fremdkapital





Fremdkapital Veränderung Datum
Assertio Holdings USD 39.17M 120K 2025-09
Astellas Pharma JPY 320B 0 2025-12
Bristol-Myers Squibb USD 42.85B 1.62B 2025-12
Cara Therapeutics USD 0 0 2025-03
Coherus Biosciences USD 51.08M 496K 2025-12
Heron Therapeutics USD 140.64M 975K 2025-12
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
J&J USD 39.44B 30M 2025-12
Ligand Pharmaceuticals USD 445.49M 445.44M 2025-09
Nektar Therapeutics USD 63.16M 44.35M 2025-12
Novo Nordisk DKK 118.94B 29.76B 2025-12
Omeros USD 403.72M 27.2M 2024-06
Pacira USD 372.19M 4.53M 2025-12
Perrigo USD 3.6B 4.5M 2025-12
Pfizer USD 57.41B 93M 2025-09
Supernus Pharmaceuticals USD 400.38M 21.13M 2022-03
Teva Pharmaceutical Industries USD 14.99B 1.78B 2025-12
Xeris Pharmaceuticals USD 220.33M 866K 2025-12
Xoma USD 94.38M 7.82M 2025-09
Zoetis USD 9.04B 1.97B 2025-12